Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Manley

Showing results (361-370 of 378) with videos related to

Pageof 38
Sort By:
Journal of Perinatology : Official Journal of the California Perinatal Association|January 27, 2026
Impact of attending neonatologist presence on neonatal intubation success and adverse events: a cohort studyClement Trinh, Kate A Hodgson, Marnie Downes, et al.
Journal for Immunotherapy of Cancer|May 4, 2026
Phase II trial of combination radiation, hormone, and immunotherapy in grade group 5 prostate cancerJohn Michael Bryant, Maria Sandoval, Ryan Putney, et al.
Pediatrics|August 29, 2023
Strengthening Reporting of Neonatal TrialsJames Webbe, Ami Baba, Nancy J Butcher, et al.
Pediatrics|August 29, 2023
Heterogeneity and Gaps in Reporting Primary Outcomes From Neonatal TrialsAmi Baba, James Webbe, Nancy J Butcher, et al.
Journal of Medicinal Chemistry|November 30, 2004
Potent N-(1,3-thiazol-2-yl)pyridin-2-amine vascular endothelial growth factor receptor tyrosine kinase inhibitors with excellent pharmacokinetics and low affinity for the hERG ion channelMark T Bilodeau, Adrienne E Balitza, Timothy J Koester, et al.
European Urology Focus|July 30, 2017
Tumor Xenografts of Human Clear Cell Renal Cell Carcinoma But Not Corresponding Cell Lines Recapitulate Clinical Response to Sunitinib: Feasibility of Using Biopsy SamplesYiyu Dong, Brandon J Manley, Maria F Becerra, et al.
JCI Insight|June 15, 2017
Genomic landscape and evolution of metastatic chromophobe renal cell carcinomaJozefina Casuscelli, Nils Weinhold, Gunes Gundem, et al.
ACS Chemical Neuroscience|August 4, 2012
Characterization of non-nitrocatechol pan and isoform specific catechol-O-methyltransferase inhibitors and substratesRonald G Robinson, Sean M Smith, Scott E Wolkenberg, et al.
Bioorganic & Medicinal Chemistry Letters|April 2, 2003
Phenylbutyrates as potent, orally bioavailable vitronectin receptor (integrin alphavbeta3) antagonistsWilliam H Miller, Peter J Manley, Russell D Cousins, et al.
Genome Biology|November 19, 2016
Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signaturesYasin Şenbabaoğlu, Ron S Gejman, Andrew G Winer, et al.
Pageof 38

Showing results (361-370 of 378) with videos related to

Sort By:
Pageof 38
Journal of Perinatology : Official Journal of the California Perinatal Association|January 27, 2026
Impact of attending neonatologist presence on neonatal intubation success and adverse events: a cohort studyClement Trinh, Kate A Hodgson, Marnie Downes, et al.
Journal for Immunotherapy of Cancer|May 4, 2026
Phase II trial of combination radiation, hormone, and immunotherapy in grade group 5 prostate cancerJohn Michael Bryant, Maria Sandoval, Ryan Putney, et al.
Pediatrics|August 29, 2023
Strengthening Reporting of Neonatal TrialsJames Webbe, Ami Baba, Nancy J Butcher, et al.
Pediatrics|August 29, 2023
Heterogeneity and Gaps in Reporting Primary Outcomes From Neonatal TrialsAmi Baba, James Webbe, Nancy J Butcher, et al.
Journal of Medicinal Chemistry|November 30, 2004
Potent N-(1,3-thiazol-2-yl)pyridin-2-amine vascular endothelial growth factor receptor tyrosine kinase inhibitors with excellent pharmacokinetics and low affinity for the hERG ion channelMark T Bilodeau, Adrienne E Balitza, Timothy J Koester, et al.
European Urology Focus|July 30, 2017
Tumor Xenografts of Human Clear Cell Renal Cell Carcinoma But Not Corresponding Cell Lines Recapitulate Clinical Response to Sunitinib: Feasibility of Using Biopsy SamplesYiyu Dong, Brandon J Manley, Maria F Becerra, et al.
JCI Insight|June 15, 2017
Genomic landscape and evolution of metastatic chromophobe renal cell carcinomaJozefina Casuscelli, Nils Weinhold, Gunes Gundem, et al.
ACS Chemical Neuroscience|August 4, 2012
Characterization of non-nitrocatechol pan and isoform specific catechol-O-methyltransferase inhibitors and substratesRonald G Robinson, Sean M Smith, Scott E Wolkenberg, et al.
Bioorganic & Medicinal Chemistry Letters|April 2, 2003
Phenylbutyrates as potent, orally bioavailable vitronectin receptor (integrin alphavbeta3) antagonistsWilliam H Miller, Peter J Manley, Russell D Cousins, et al.
Genome Biology|November 19, 2016
Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signaturesYasin Şenbabaoğlu, Ron S Gejman, Andrew G Winer, et al.
Pageof 38